E. Davis - 03 Mar 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
CEO and President, Director
Signature
Sean D. Mersten, Attorney in Fact for James E. Davis
Issuer symbol
DGX
Transactions as of
03 Mar 2025
Transactions value $
$4,968,790
Form type
4
Filing time
05 Mar 2025, 16:37:24 UTC
Previous filing
28 Feb 2025
Next filing
04 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Tax liability -$289K -1.66K -1.2% $173.74 137K 03 Mar 2025 Direct F1
transaction DGX Common Stock Award $10.8M +61.9K +45.34% $173.74 198K 04 Mar 2025 Direct F2
transaction DGX Common Stock Tax liability -$5.5M -31.7K -15.95% $173.74 167K 04 Mar 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
F2 Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock awards approved in accordance with the requirements of Rule 16b-3(d).
F3 Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock awards.